Malignant transformation of oral lichen planus and related genetic factors
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Oral lichen planus (OLP) is a chronic inflammatory disease observed in approximately 0.5–2.2% of the population, and it is recognized as a premalignant lesion that can progress into oral squamous cell carcinoma (OSCC). The rate of malignant transformation is approximately 1.09–2.3%, and the risk factors for malignant transformation are age, female, erosive type, and tongue site location. Malignant transformation of OLP is likely related to the low frequency of apoptotic phenomena. Therefore, apoptosis-related genetic factors, like p53, BCL-2, and BAX are reviewed. Increased p53 expression and altered expression of BCL-2 and BAX were observed in OLP patients, and the malignant transformation rate in these patients was relatively higher. The involvement of microRNA (miRNA) in the malignant transformation of OLP is also reviewed. Because autophagy is involved in cell survival and death through the regulation of various cellular processes, autophagy-related genetic factors may function as factors for malignant transformation. In OLP, decreased levels of ATG9B mRNA and a higher expression of IGF1 were observed, suggesting a reduction in cell death and autophagic response. Activated IGF1-PI3K/AKT/mTor cascade may play an important role in a signaling pathway related to the malignant transformation of OLP to OSCC. Recent research has shown that miRNAs, such as miR-199 and miR-122, activate the cascade, increasing the prosurvival and proproliferative signals.
Abstract
Oral lichen planus (OLP) is a chronic inflammatory disease observed in approximately 0.5–2.2% of the population, and it is recognized as a premalignant lesion that can progress into oral squamous cell carcinoma (OSCC). The rate of malignant transformation is approximately 1.09–2.3%, and the risk factors for malignant transformation are age, female, erosive type, and tongue site location. Malignant transformation of OLP is likely related to the low frequency of apoptotic phenomena. Therefore, apoptosis-related genetic factors, like p53, BCL-2, and BAX are reviewed. Increased p53 expression and altered expression of BCL-2 and BAX were observed in OLP patients, and the malignant transformation rate in these patients was relatively higher. The involvement of microRNA (miRNA) in the malignant transformation of OLP is also reviewed. Because autophagy is involved in cell survival and death through the regulation of various cellular processes, autophagy-related genetic factors may function as factors for malignant transformation. In OLP, decreased levels of ATG9B mRNA and a higher expression of IGF1 were observed, suggesting a reduction in cell death and autophagic response. Activated IGF1-PI3K/AKT/mTor cascade may play an important role in a signaling pathway related to the malignant transformation of OLP to OSCC. Recent research has shown that miRNAs, such as miR-199 and miR-122, activate the cascade, increasing the prosurvival and proproliferative signals.
참고문헌 (70)
- Zhang L, "Molecular analysis of oral lichen planus. A premalignant lesion?", Am J Pathol, 151, pp.323~327 (1997)
- Simona Roxana Georgescu, "Reflectometric Analysis for Identification of Various Pathological Conditions Associated with Lichen Planus", Revista de Chimie, 68(5), pp.1103~1108 (2017), Revista de Chimie SRL[DOI]
- Giannetti L, "Oral lichen planus", J Biol Regul Homeost Agents, 32, pp.391~395 (2018)
- David Farhi, "Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies", Clinics in Dermatology, 28(1), pp.100~108 (2010), Elsevier BV[DOI]
- E. Torrente-Castells, "Clinical features of oral lichen planus. A retrospective study of 65 cases", Medicina Oral Patología Oral y Cirugia Bucal, pp.e685~e690 (2009), Medicina Oral, S.L[DOI]
- Gian Paolo Bombeccari, "Oral lichen planus and malignant transformation: a longitudinal cohort study", Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 112(3), pp.328~334 (2011), Elsevier BV[DOI]
- ZY. Shen, "A retrospective clinicopathological study on oral lichen planus and malignant transformation: Analysis of 518 cases", Medicina Oral Patología Oral y Cirugia Bucal, 17, pp.e943~e947 (2012), Medicina Oral, S.L[DOI]
- Elena Bardellini, "Clinicopathological features and malignant transformation of oral lichen planus: A 12-years retrospective study", Acta Odontologica Scandinavica, 71(3-4), pp.834~840 (2012), Informa UK Limited[DOI]
- S. Silverman, "A prospective follow-up study of 570 patients with oral lichen planus: Persistence, remission, and malignant association", Oral Surgery, Oral Medicine, Oral Pathology, 60(1), pp.30~34 (1985), Elsevier BV[DOI]
- Gang Zhou, "Increased B7-H1 Expression on Peripheral Blood T Cells in Oral Lichen Planus Correlated with Disease Severity", Journal of Clinical Immunology, 32(4), pp.794~801 (2012), Springer Science and Business Media LLC[DOI]
- Guido Lorenzini, "A comparative immunohistochemical and immunophenotypical study on lymphocytes expression in patients affected by oral lichen planus", Journal of Oral Pathology & Medicine, 42(8), pp.642~647 (2013), Wiley[DOI]
- Sarah G. Fitzpatrick, "The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review", The Journal of the American Dental Association, 145(1), pp.45~56 (2014), Elsevier BV[DOI]
- Michele Giuliani, "Rate of malignant transformation of oral lichen planus: A systematic review", Oral Diseases, 25(3), pp.693~709 (2018), Wiley[DOI]
- Zheng-Yu Shen, "Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation?", Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 112(5), pp.592~596 (2011), Elsevier BV[DOI]
- Qiao Peng, "Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation?", Expert Review of Clinical Immunology, 13(6), pp.635~643 (2017), Informa UK Limited[DOI]
- Sana Maher Hasan Aghbari, "Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data", Oral Oncology, 68, pp.92~102 (2017), Elsevier BV[DOI]
- Abbate G, "Neoplastic transformation of oral lichen : case report and review of the literature", Acta Otorhinolaryngol Ital, 26, pp.47~52 (2006)
- Michael Z. Marder, "Transformation of Oral Lichen Planus to Squamous Cell Carcinoma: A Literature Review and Report of Case", The Journal of the American Dental Association, 105(1), pp.55~60 (1982), Elsevier BV[DOI]
- Valerie Laniosz, "Incidence of squamous cell carcinoma in oral lichen planus: a 25-year population-based study", International Journal of Dermatology, 58(3), pp.296~301 (2019), Wiley[DOI]
- Pascal Meier, "Apoptosis in development", Nature, 407(6805), pp.796~801 (2000), Springer Science and Business Media LLC[DOI]
- C Bascones-Ilundain, "No differences in caspase-3 and Bax expression in atrophic-erosive vs. reticular oral lichen planus", Journal of the European Academy of Dermatology and Venereology, 22, pp.204~212 (2007), Wiley[DOI]
- C GOTZ, "P53 AND ITS IMPLICATION IN APOPTOSIS (REVIEW)", International Journal of Oncology, 6, pp.1129~1135 (1995), Spandidos Publications[DOI]
- Jiandong Chen, "The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression", Cold Spring Harbor Perspectives in Medicine, 6(3), pp.a026104~ (2016), Cold Spring Harbor Laboratory[DOI]
- Meital Charni, "p53 on the crossroad between regeneration and cancer", Cell Death & Differentiation, 24(1), pp.8~14 (2017), Springer Science and Business Media LLC[DOI]
- Naoko Tanda, "Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies", Journal of Oral Pathology & Medicine, 29(8), pp.385~393 (2000), Wiley[DOI]
- Cruz IB, "p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma", J Pathol, 184, pp.360~368 (1998)[DOI]
- MG Oliveira Alves, "Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus", Oral Diseases, 19(8), pp.775~780 (2013), Wiley[DOI]
- Mark Wade, "Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells", Journal of Biological Chemistry, 281(44), pp.33036~33044 (2006), Elsevier BV[DOI]
- Shailaja G, "Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers", Dent Res J(Isfahan), 12, pp.235~242 (2015)
- Y. Taniguchi, "Epithelial cell proliferation in oral lichen planus", Cell Proliferation, 35(Suppl 1), pp.103~109 (2002), Wiley[DOI]
- Ashraf Fakhrjou, "Morphologic Evaluation of P53 Apoptotic Signaling Responses and Proliferative Activity of Ki-67 in Oral Lichen Planus, Oral Squamous Cell Carcinoma and Normal Specimens", Journal of Medical Sciences, 12(2), pp.51~56 (2012), Science Alert[DOI]
- Renata Rodrigues Acay, "Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67", Oral Oncology, 42(5), pp.475~480 (2006), Elsevier BV[DOI]
- Guido Valente, "Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution", Journal of Oral Pathology & Medicine, 30(3), pp.135~140 (2001), Wiley[DOI]
- Agha-Hosseini F, "Unstimulated salivary p53 in patients with oral lichen planus and squamous cell carcinoma", Acta Med Iran, 53, pp.439~443 (2015)
- Tilman Oltersdorf, "An inhibitor of Bcl-2 family proteins induces regression of solid tumours", Nature, 435(7042), pp.677~681 (2005), Springer Science and Business Media LLC[DOI]
- Frank Edlich, "BCL-2 proteins and apoptosis: Recent insights and unknowns", Biochemical and Biophysical Research Communications, 500(1), pp.26~34 (2018), Elsevier BV[DOI]
- Richard S. Hotchkiss, "Cell Death", New England Journal of Medicine, 361(16), pp.1570~1583 (2009), Massachusetts Medical Society[DOI]
- Hui-Chen Chen, "An interconnected hierarchical model of cell death regulation by the BCL-2 family", Nature Cell Biology, 17(10), pp.1270~1281 (2015), Springer Science and Business Media LLC[DOI]
- Kirsteen J. Campbell, "Targeting BCL-2 regulated apoptosis in cancer", Open Biology, 8(5), pp.180002~ (2018), The Royal Society[DOI]
- Zoltán N. Oltval, "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death", Cell, 74(4), pp.609~619 (1993), Elsevier BV[DOI]
- D Westphal, "Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis", Cell Death & Differentiation, 21(2), pp.196~205 (2014), Springer Science and Business Media LLC[DOI]
- A. M. Abdel-Latif, "Increased caspase-3 and altered expression of apoptosis-associated proteins, Bcl-2 and Bax in lichen planus", Clinical and Experimental Dermatology, 34(3), pp.390~395 (2009), Wiley[DOI]
- Arreaza AJ, "Expression of COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions", Ecancermedicalscience, 8, pp.411~ (2014)[DOI]
- Li XR, "The expression and changes of apoptosis protein Bcl-2 and Bax in oral lichen planus", Shanghai Kou Qiang Yi Xue, 24, pp.465~469 (2015)
- Fernanda Mombrini Pigatti, "Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia", International Journal of Dermatology, 54(2), pp.150~155 (2015), Wiley[DOI]
- Fernando A. C. G. de Sousa, "Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia", Journal of Oral Science, 51(1), pp.117~121 (2009), Nihon University School of Dentistry[DOI]
- JI-AE SHIN, "Myeloid cell leukemia-1 is a molecular indicator for malignant transformation of oral lichen planus", Oncology Letters, 11(2), pp.1603~1607 (2016), Spandidos Publications[DOI]
- Sutariya RV, "Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma", J Exp Ther Oncol, 11, pp.285~292 (2016)
- Victor Ambros, "The functions of animal microRNAs", Nature, 431(7006), pp.350~355 (2004), Springer Science and Business Media LLC[DOI]
- Thomas X. Lu, "MicroRNA", Journal of Allergy and Clinical Immunology, 141(4), pp.1202~1207 (2018), Elsevier BV[DOI]
- H-W Hwang, "MicroRNAs in cell proliferation, cell death, and tumorigenesis", British Journal of Cancer, 94(6), pp.776~780 (2006), Springer Science and Business Media LLC[DOI]
- Volker Gassling, "Disease-Associated miRNA-mRNA Networks in Oral Lichen Planus", PLoS ONE, 8(5), pp.e63015~ (2013), Public Library of Science (PLoS)[DOI]
- Hui Ma, "MicroRNAs in oral lichen planus and potential miRNA–mRNA pathogenesis with essential cytokines: a review", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 122(2), pp.164~173 (2016), Elsevier BV[DOI]
- Junjun Chen, "Down‐regulation of miRNA‐27b‐3p suppresses keratinocytes apoptosis in oral lichen planus", Journal of Cellular and Molecular Medicine, 23(6), pp.4326~4337 (2019), Wiley[DOI]
- Bin Zhao, "Vitamin D", VDR signaling suppresses microRNA‐802‐induced apoptosis of keratinocytes in oral lichen planus, 2018, pp.33(1), 1042~1050[DOI]
- Jie Du, "MicroRNA-26a", b have protective roles in oral lichen planus, 2020, pp.11(1), 15~[DOI]
- Beth Levine, "Autophagy in the Pathogenesis of Disease", Cell, 132(1), pp.27~42 (2008), Elsevier BV[DOI]
- Noboru Mizushima, "Autophagy: Renovation of Cells and Tissues", Cell, 147(4), pp.728~741 (2011), Elsevier BV[DOI]
- Eric H. Baehrecke, "Autophagy: dual roles in life and death?", Nature Reviews Molecular Cell Biology, 6(6), pp.505~510 (2005), Springer Science and Business Media LLC[DOI]
- Beth Levine, "Autophagy in immunity and inflammation", Nature, 469(7330), pp.323~335 (2011), Springer Science and Business Media LLC[DOI]
- Tan YQ, "Altered autophagy-associated genes expression in T cells of oral lichen planus correlated with clinical features", Mediators Inflamm, 2016, pp.4867368~ (2016)[DOI]
- Yiping Gu, "Effect of IGF-1 on the balance between autophagy of dysfunctional mitochondria and apoptosis", FEBS Letters, 577(3), pp.357~360 (2004), Wiley[DOI]
- Troncoso R, "Energy-preserving effects of IGF-1 antagonize starvationinduced cardiac autophagy", Cardiovasc Res, 93, pp.320~329 (2012)[DOI]
- Fang Wang, "Insulin-like growth factor 1 exhibits the pro-autophagic and anti-apoptotic activity on T cells of oral lichen planus", International Journal of Biological Macromolecules, 133, pp.640~646 (2019), Elsevier BV[DOI]
- Terry J. Smith, "Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?", Pharmacological Reviews, 62(2), pp.199~236 (2010), American Society for Pharmacology & Experimental Therapeutics (ASPET)[DOI]
- Jiayao Fu, "miR-199a-3p is involved in estrogen-mediated autophagy through the IGF-1", mTOR pathway in osteocyte-like MLO-Y4 cells, 2018, pp.233(3), 2292~2303[DOI]
- Rui-Jie Ma, "Aberrant IGF1–PI3K", AKT, Immunobiology, pp.2019, 224(3)[DOI]
- Na Zhang, "Activated Akt", mTOR-autophagy in local T cells of oral lichen planus, 2017, pp.48, 84~90[DOI]
- Liang Wang, "miR‑122 and miR‑199 synergistically promote autophagy in oral lichen planus by targeting the Akt", mTOR pathway, 2019, pp.43, 1373~1381[DOI]
- M. R. Roopashree, "Pathogenesis of oral lichen planus - a review", Journal of Oral Pathology & Medicine, 39(10), pp.729~734 (2010), Wiley[DOI]
